Sat, Jul 12, 2014, 6:33 AM EDT - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

US Airways Group, Inc. Message Board

joesolomon333 253 posts  |  Last Activity: 8 hours ago Member since: Oct 23, 2012
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • joesolomon333 by joesolomon333 Apr 27, 2014 2:43 AM Flag

    To see what idiot is going bash and short SPPI UP from $6 to $25. Enjoy the ride. Bought another 10,000 shares in the last 2 weeks. Thank you. See you at $25 when the real games begin when SPPI has $300 to $500 MM in revenue and should be a 6 multiple of revenues.

    If not, I will wait for the pipeline.

  • Reply to

    Just Checking In

    by joesolomon333 Apr 27, 2014 2:43 AM
    joesolomon333 joesolomon333 Apr 27, 2014 2:53 AM Flag

    Before shortsht gets his/her panties in a wad:

    I mean $300 MM plus with Belinostat and Capistro-enabled Melphalan only. SP-2012 and on and on and on is the pipeline.

  • Reply to

    Just Checking In

    by joesolomon333 Apr 27, 2014 2:43 AM
    joesolomon333 joesolomon333 Apr 27, 2014 3:22 AM Flag

    Going to buy an additional 30,000 shares too so I hope it stays where it is a little longer.

  • Reply to

    Watch it....:)

    by Jun 5, 2014 3:08 PM
    joesolomon333 joesolomon333 Jun 5, 2014 11:05 PM Flag

    Sorry, dk.
    I have no aliases. Don't need any.

    I also have bought an additional 12,000 shares since my last message. 18,000 more to go. Talk to you at $25 PPS plus.

    P.S. Let me know of another BioTech with $160MM in revenues, cash flow breakeven (which is non-GAAP if you do not know), has $120MM in cash) and has a Market Cap of $500MM or so.

    P.S.S. There are none. Most would be 5 to 9 times EXISTING revenues or 3 TIMES Max Pipeline, if greater.

    Run the numbers. Let's start with $1.4 BILLION today which is low $20's PPS .

    That is not even counting the PIPELINE which is off the chart. Let's chat in 2016. I intend to own 1% or more of the entire Company.

  • joesolomon333 by joesolomon333 Feb 12, 2014 11:28 PM Flag

    I am leaving the board as I feel that is the best for everyone. It is my decision and I wish each of you and SPPI the very best in Helping to Beat Cancer. I will continue to invest in and follow SPPI going forward as I do not believe there is a more undervalued biotech on Planet Earth.

    No need to respond as it does not matter.

    I reserve the right to come back and Congratulate everyone at $25 and again at every $5 PPS increment thereafter or so. Otherwise, I wish everyone the very best in life, health and happiness.

    Best regards always! Joe

  • joesolomon333 by joesolomon333 Jan 29, 2014 9:26 PM Flag

    I will let you leave the board and will never say a derogatory word about you again unless you post again on the board. Those are my terms and they are nonnegotiable.

    Otherwise, please reply to the following:
    1. How is the class action lawsuit going?
    2. How is that FDA so called "warning letter" going for you?
    3. How is the FDA investigation.

    Please provide authority and updates on all the above. P.S. You can't. You are lying.

    4. Please explain how you can possibly lose coming down to $6.92 and back UP to $8.53 PPS.

    Loser "coming and going". You can leave silently with your tail between your legs and I will not refer to you again. Once again, nonnegotiable.

  • Reply to

    market correction takes SPPI down to $5..

    by matrixtrade123 Jan 25, 2014 12:01 AM
    joesolomon333 joesolomon333 Jan 25, 2014 12:08 AM Flag

    Please go to rehab. You need it desperately.

  • joesolomon333 by joesolomon333 Jul 7, 2014 10:52 PM Flag

    1. SPPI is controlled by the TUTES and Shorts and some are the same.
    2. SPPI is severely, severely undervalued.
    3. SPPI has a diversified and extensive Pipeline in multi-billion dollar markets, 5 FDA approved drugs with number 6 on the way,$160 to $180 MILLION in existing revenues, very little dilution, extensive cash, only 63 million shares outstanding and is at a 3 to 3.5 revenue multiple and other Biotechs are at 8 to 17 times revenues.
    4. SPPI just needs to keep growing revenues and the valuation will take care of itself.
    5. Capistrol-enabled Melphalan, Apaziquone and SPI-2012 are hitting next in the order.
    6. At some point the Tutes and Shorts will stop the merry go round and will go all in long if SPPI keeps moving forward, much less if one or more of the SPPI Pipeline drugs hit like SPI-2012, Apaziquone or SPI-1620. Game Over. Will make DNDN look like a drone not a rocket ship.

  • joesolomon333 by joesolomon333 Jan 16, 2014 10:01 PM Flag

    SPPI is now a SEVEN Bagger in the last 64 months and is up OVER 41 PERCENT since March 21st with imho crying and whining all the way.

  • That Ride Up from $6.92 to $9.56 PPS since March 21st really undermines the agenda:

    iome 70
    your_gal_loves_my_viagra Less

  • Not coming back until $25 PPS but.......I hate liars...... who either cannot read or are intentionally misleading. What a complete dumbxxx, To be clear:

    "Change In Control Severance Agreements
    On March 25, 2014, the Committee approved and adopted a form of Change In Control Severance Agreement (the “ Severance Agreement ”) to be entered into with the Company’s named executive officers (OTHER THAN THE CHIEF EXECUTIVE OFFICER)

  • Reply to

    A challenge for stocktoshort.

    by mnm29875 Jan 20, 2014 9:04 PM
    joesolomon333 joesolomon333 Jan 20, 2014 11:35 PM Flag

    There are no aliases. I don't need any. There also is no intellectual bantering. That implies a two way dialogue. It is one way. I don't even need to take my warm ups off for you.

    How does the RIDE UP from $6.92 to $9.88 feel since March 21st much less the 65 month SEVEN BAGGER from $1.39 to $9.8 PPS?

    True Facts. Not Lies like you. Leaving the board, koala bear?

  • Reply to

    A challenge for stocktoshort.

    by mnm29875 Jan 20, 2014 9:04 PM
    joesolomon333 joesolomon333 Jan 21, 2014 12:35 AM Flag

    Dude, go get help. You are truly paranoid. No are running scared of ghosts. Seek help.

  • joesolomon333 joesolomon333 Jan 25, 2014 12:13 AM Flag

    Yes, Candide you are right.
    "HENDERSON, Nev.--(BUSINESS WIRE)-- Spectrum Pharmaceuticals (SPPI), a biotechnology company with fully integrated commercial and drug development operations with a primary focus in hematology and oncology, today announced the Company has reacquired development and commercialization rights for apaziquone in the United States, Europe and other territories pursuant to an agreed-upon restructuring of Spectrum’s collaboration with Allergan, Inc. In exchange, Allergan will receive a royalty on future revenue. Apaziquone is an anticancer agent being developed for the treatment of non-muscle invasive bladder cancer (NIMBC) as a single instillation following transurethral resection of bladder tumor (TURBT)."

  • joesolomon333 joesolomon333 Feb 4, 2014 9:22 AM Flag

    Idiot. Your statement was regarding the PPS movement and SPPI being a Six Bagger in PPS Increase over 5 years, NOT to the net income or market cap.

    Yes, their PPS multiples and being Six Baggers are similiar. And the fact that their peak PPS was higher but they are BOTH STILL Six Baggers.

  • joesolomon333 joesolomon333 Jan 25, 2014 12:14 AM Flag

    SPPI already owned ALL of ASIA.

  • joesolomon333 by joesolomon333 Jan 24, 2014 10:33 PM Flag

    Spectrum has FOUR FDA-approved oncology/hematology products and THREE products in late-stage development. The Company also has as a DIVERSIFIED portfolio of proprietary drugs in various stages of development, with a focus on oncology/hematology.

    Go to the website and click any area on the chart to learn more on a specific drug and the EXTENSIVE PIPELINE.

  • joesolomon333 by joesolomon333 Jan 23, 2014 11:29 AM Flag

    SPPI has all rights to Apaziquone in Asia including China and Japan.

    Allergan and SPPI will share 50/50 equally in all U.S. profits and expenses and Allergan will pay SPPI royalties of up to $300 Million for sales in the rest of the world other than the U.S. and Asia.

    Thus, Allergan paid $41 Million for the right to share profits 50/50 with SPPI in the U.S. plus royalties of up to $300 Million for the ROW sales other than ASIA as SPPI continues to own 100% of all rights to Apaziquone in Asia.

  • The bear position is getting ready to be wrong for 52 weeks year-over-year on this Six Bagger.

  • It is now to the point of being willful and intentional on your part. Since March 21st under the NEW Management Team the PPS is up from $6.92 to $10.16. OVER a 46% RETURN in 10 Months.

    The NEW Management Team is executing beautifully.

    No telling the extent of the damages you have cost unknowing investors. And, yes, SPPI is a SEVEN BAGGER since September 2008.

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.